← Evidence map

Observational studyDrug design, development and therapy2023

The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19.

Shih-Lung Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36698540